E-LIB Suche - Ergebnisse für: Pellissier, D.

1

Paleoenvironments shaped the exchange of terrestrial verteb..:

Skeels, A. ; Boschman, L. M. ; McFadden, I. R....
Science. 381 (2023) 6653 - p. 86-92 , 2023

Link: https://doi.org/10.1126/..

2

Temperature-Dependent Evolutionary Speed Shapes the Evoluti..:

Skeels, A ; Bach, W ; Hagen, O...
Systematic Biology. 72 (2022) 2 - p. 341-356 , 2022

Link: https://doi.org/10.1093/..

3

Coral reef fishes reveal strong divergence in the prevalenc..:

Parravicini, V. ; Bender, M. G. ; Villéger, S....
Proceedings of the Royal Society B: Biological Sciences. 288 (2021) 1961 - p. , 2021

Link: https://doi.org/10.1098/..

4

PCN266 ONCOLOGY SEQUENCE MODELS IN HEALTH TECHNOLOGY ASSESS..:

Xue, W. ; Huang, M. ; Ramsey, S.D....
Value in Health. 23 (2020) - p. S69-S70 , 2020

Link: https://doi.org/10.1016/..

5

A Holistic Approach to Evaluate the Cost-Effectiveness of P..:

Wu, E ; Pellissier, J ; Kvamme, M.
Value in Health. 21 (2018) - p. S7 , 2018

Link: https://doi.org/10.1016/..

6

PMU30 - BUDGET AND HEALTH IMPACT OF IMMUNO-ONCOLOGY TREATME..:

Lucherini, S ; van Bavel, J. ; Polistena, B...
Value in Health. 21 (2018) - p. S313 , 2018

Link: https://doi.org/10.1016/..

7

PCN345 - HEALTH STATE UTILITIES IN METASTATIC NSCLC: A STUD..:

Huang, M. ; Chandwani, S. ; Insinga, R....
Value in Health. 21 (2018) - p. S72-S73 , 2018

Link: https://doi.org/10.1016/..

8

A Long‐Term Watershed‐Scale Partnership to Restore Bull Tro..:

Buktenica, M. W. ; Hering, D. K. ; Scott, N....
Fisheries. 43 (2018) 4 - p. 183-193 , 2018

Link: https://doi.org/10.1002/..

9

Cost-Effectiveness of Pembrolizumab (Keytruda®) Versus Ipil..:

Wang, J ; Chabot, I ; El-Hadi, W...
Value in Health. 19 (2016) 3 - p. A153-A154 , 2016

Link: https://doi.org/10.1016/..

10

Healthcare Resource Utilization in Patients Receiving Pembr..:

Huang, M ; Pellissier, J ; Liao, J
Value in Health. 19 (2016) 7 - p. A755 , 2016

Link: https://doi.org/10.1016/..

11

A Trial-Based Euroqol Eq-5d Health Utility Analysis in Pati..:

Huang, M ; Pellissier, J ; Liao, J
Value in Health. 19 (2016) 7 - p. A744 , 2016

Link: https://doi.org/10.1016/..

12

Cost Effectiveness of Pembrolizumab (Keytruda®) Versus Ipil..:

Wang, J ; Pellissier, J ; Xu, R...
Value in Health. 19 (2016) 3 - p. A154 , 2016

Link: https://doi.org/10.1016/..

13

Cost-Effectiveness of Pembrolizumab for Advanced Melanoma T..:

Silva Miguel, L ; Vargas Lopes, F ; Pinheiro, B...
Value in Health. 19 (2016) 7 - p. A729 , 2016

Link: https://doi.org/10.1016/..

14

Cost-Effectiveness of Pembrolizumab in Patients with Advanc..:

Silva Miguel, L ; Vargas Lopes, F ; Pinheiro, B...
Value in Health. 19 (2016) 7 - p. A730 , 2016

Link: https://doi.org/10.1016/..

15

Cost-Effectiveness of Pembrolizumab vs. Docetaxel for Treat..:

Huang, M ; Lou, Y ; Pellissier, J...
Value in Health. 19 (2016) 7 - p. A737 , 2016

Link: https://doi.org/10.1016/..